UK markets closed

DMS Imaging SA (0RGO.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
0.0160+0.0015 (+10.34%)
At close: 02:32PM GMT

DMS Imaging SA

Avenue Louise 231
Ixelles 1050
32 4 67 50 49 00

Full-time employees120

Key executives

NameTitlePayExercisedYear born
Mr. Frank HazevoetsMD, CEO, CFO & DirectorN/AN/A1966
Dr. Vincent Bille Ph.D.Head of Technical OperationsN/AN/AN/A
Attorney M. Grégory NihonCompliance Officer & General SecretaryN/AN/AN/A
Mr. François GaryBusiness Development & Marketing DirectorN/AN/AN/A
Ms. Marie Pierre BeaumontHead of Human ResourcesN/AN/AN/A
Ms. Béatrice De Vos Bcpm, M.D., Ph.D.Chief Medical Officer7.5kN/AN/A
Mr. Philippe GhemHead of Commercial Operations & LicensingN/AN/AN/A
Mr. Rémy von FrenckellHead of Clinical DevelopmentN/AN/AN/A
Ms. Martine DraguetHead of Regulatory Affairs & Quality AssuranceN/AN/AN/A
Amounts are as of 31 December 2017, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.


DMS Imaging SA engages in the design, development, and manufacturing of medical imaging systems for digital radiology and bone densitometry in Belgium. It offers R/F solutions, including PLATINUM NEO, a smart solution that revolutionizes the R/F workflow, as well as OPTIMA dRF, a robust solution; bone densitometry and body composition analysis equipment; chest and bone rooms, such as floor and ceiling tube stands; ambulatory radiography equipment; retrofit kits; C-ARM mobile operating room solutions; and mammography solutions. The company was formerly known as ASIT Biotech S.A. and changed its name to DMS Imaging SA in February 2022. DMS Imaging SA was incorporated in 1997 and is headquartered in Ixelles, Belgium. DMS Imaging SA operates as a subsidiary of Diagnostic Medical Systems S.A.

Corporate governance

DMS Imaging SA’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.